Comparison of patient ‐reported acute urinary and sexual toxicity scores in a 6‐ versus 2‐fraction course of high‐dose‐rate prostate brachytherapy monotherapy

ConclusionNo increased acute genitourinary or sexual dysfunction has been observed in men when transitioning from 6‐fraction to 2‐fraction HDR monotherapy. A dosimetric correlation was found between the V150 and bladder wall doses for acute urinary toxicity. Future research should continue to standardize and validate dose constraints for prostate HDR monotherapy patients.

Source: Australasian Radiology - August 1, 2017 Category: Radiology Authors: Omar Ragab, Robyn Banerjee, Sang ‐June Park, Shyamal Patel, Mingle Zhang, Jason Wang, Maria Velez, David Jeffrey Demanes, Mitchell Kamrava Tags: Radiation Oncology —Original Article Source Type: research